Innovation
2 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 50 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Developer of Ribonucleoprotein complex based antiviral therapeutics for HIV treatment
2 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 50 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |